Research programme: coronavirus vaccine - Vaxil BioTherapeutics
Alternative Names: Corvax; COVID-19 vaccine - Vaxil BioTherapeuticsLatest Information Update: 04 Dec 2021
At a glance
- Originator Vaxil BioTherapeutics
- Class COVID-19 vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Coronavirus infections
Highest Development Phases
- Suspended COVID 2019 infections